3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Completed
2
Sponsor Class
OTHER
3
NETWORK
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
1
Conditions
Carcinoma, Non-Small-Cell Lung
73
Lung Neoplasms
64
Breast Neoplasms
63
Lymphoma
58
Ovarian Neoplasms
51
Leukemia
44
Sarcoma
43
Prostatic Neoplasms
39
Multiple Myeloma
36
Head and Neck Neoplasms
36
Central Nervous System Neoplasms
36
Squamous Cell Carcinoma of Head and Neck
32
Colorectal Neoplasms
31
Carcinoma, Ovarian Epithelial
30
Melanoma
29
Rectal Neoplasms
28
Neoplasm Metastasis
27
Uterine Cervical Neoplasms
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Lymphoma, Large B-Cell, Diffuse
26
Brain Neoplasms
26
Urinary Bladder Neoplasms
24
Leukemia, Lymphocytic, Chronic, B-Cell
24
Leukemia, Myeloid, Acute
23
Fallopian Tube Neoplasms
23
Endometrial Neoplasms
22
Glioblastoma
21
Adenocarcinoma of Lung
21
Lymphoma, Mantle-Cell
18
Gliosarcoma
17
Interventions
eribulin
1
Trabectedin
1
Doxorubicin
1
Dacarbazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
NETWORK
×
Solitary Fibrous Tumors
×
Clear all
NCT03023124
2024-12-09
STRADA
Italian Sarcoma Group
Phase 2
Completed
23 enrolled
NCT03840772
2024-09-20
ERASING
Italian Sarcoma Group
Phase 2
Completed
16 enrolled